Medical Marijuana (Medical Marijuana) Capex-to-Revenue : 1.71 (As of Dec. 2017)

View and export this data going back to 2011. Start your Free Trial

What is Medical Marijuana Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Medical Marijuana's Capital Expenditure for the six months ended in Dec. 2017 was $-45.37 Mil. Its Revenue for the six months ended in Dec. 2017 was $26.52 Mil.

Hence, Medical Marijuana's Capex-to-Revenue for the six months ended in Dec. 2017 was 1.71.

Medical Marijuana Capex-to-Revenue Historical Data

The historical data trend for Medical Marijuana's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medical Marijuana Capex-to-Revenue Chart

Medical Marijuana Annual Data

Trend

Dec09

Dec10

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Capex-to-Revenue

Get a 7-Day Free Trial

0.04

1.71

Medical Marijuana Semi-Annual Data
	Dec09	Dec10	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17
Capex-to-Revenue	Get a 7-Day Free Trial			-	0.04	-	-	1.71

Competitive Comparison of Medical Marijuana's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Medical Marijuana's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medical Marijuana's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medical Marijuana's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Medical Marijuana's Capex-to-Revenue falls into.

Medical Marijuana Capex-to-Revenue Calculation

Medical Marijuana's Capex-to-Revenue for the fiscal year that ended in Dec. 2017 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-45.367)	/	26.523
	=	1.71

Medical Marijuana's Capex-to-Revenue for the quarter that ended in Dec. 2017 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-45.367)	/	26.523
	=	1.71

Medical Marijuana (OTCPK:MJNA) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

Medical Marijuana Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Medical Marijuana's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Medical Marijuana (Medical Marijuana) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medical Marijuana Inc (OTCPK:MJNA) » Definitions » Capex-to-Revenue

Traded in Other Exchanges

N/A

Address

2384 La Mirada Drive, Vista, CA, USA, 92081

Website

https://www.medicalmarijuanainc.com

Medical Marijuana Inc is engaged in the development, sale, and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol and other products containing CBD-rich hemp oil. The company's products are used by pharmaceutical, nutraceutical, and cosmeceutical industries. Some of its products are CBD Capsules, CBD Tinctures, Vaporizers, and Hemp foods among others.